abrdn U.S. Closed-End Funds Announce Distribution Payment Details - StockTitan
| THQ Fund | USD 19.95 0.03 0.15% |
Slightly above 56% of Tekla Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Tekla Healthcare Opportunities fund suggests that many investors are alarmed at this time. Tekla Healthcare's investing sentiment overview a quick insight into current market opportunities from investing in Tekla Healthcare Opportunities. Many technical investors use Tekla Healthcare Opp fund news signals to limit their universe of possible portfolio assets and to time the market correctly.
Tekla |
abrdn U.S. Closed-End Funds Announce Distribution Payment Details StockTitan
Read at news.google.com
 |
Tekla Healthcare Fundamental Analysis
We analyze Tekla Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Tekla Healthcare is currently under evaluation in beta among similar funds. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Tekla Healthcare Opp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tekla Healthcare fund to make a market-neutral strategy. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics with similar companies.
Peers
Tekla Healthcare Related Equities
| CCD | Calamos Dynamic | 2.10 | ||||
| BCX | Blackrock Resources | 1.54 | ||||
| RVT | Royce Value | 1.12 | ||||
| RQI | Cohen Steers | 0.71 | ||||
| BTO | John Hancock | 0.69 | ||||
| UTG | Reaves Utility | 0.69 | ||||
| THW | Tekla World | 0.60 | ||||
| ETO | Eaton Vance | 0.51 | ||||
| RNP | Cohen Steers | 0.38 | ||||
| FLC | Flaherty Crumrine | 0.24 | ||||
| PTY | Pimco Corporate | 0.14 | ||||
| FFC | Flaherty Crumrine | 0.13 | ||||
| LDP | Cohen Steers | 0.1 | ||||
| HQH | Tekla Healthcare | 0.06 | ||||
| HQL | Tekla Life | 0.37 | ||||
| XFLT | XAI Octagon | 0.92 |
Other Information on Investing in Tekla Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |